- Home
- GEN vs HOLX Comparison
GEN vs HOLX Comparison
Compare GEN & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GEN | HOLX |
|---|---|---|
| Founded | 1982 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Electronics |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8B | 16.6B |
| IPO Year | 1995 | 1995 |
Fundamental Metrics
Financial Performance| Metric | GEN | HOLX |
|---|---|---|
| Price | $21.87 | $75.47 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 13 |
| Target Price | $33.63 | ★ $77.89 |
| AVG Volume (30 Days) | ★ 6.0M | 2.2M |
| Earning Date | 05-07-2026 | 04-27-2026 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | ★ 7.29 | N/A |
| EPS | 0.74 | ★ 0.79 |
| Revenue | ★ $6,676,000,000.00 | $4,100,500,000.00 |
| Revenue This Year | $27.40 | $4.74 |
| Revenue Next Year | $5.49 | $5.03 |
| P/E Ratio | ★ $30.65 | $95.81 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $21.33 | $51.90 |
| 52 Week High | $32.22 | $75.75 |
Technical Indicators
Market Signals| Indicator | GEN | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 37.58 | 56.96 |
| Support Level | $21.33 | $75.20 |
| Resistance Level | $27.24 | N/A |
| Average True Range (ATR) | 0.61 | 0.22 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 30.77 | 65.62 |
Price Performance
Historical ComparisonAbout GEN Gen Digital Inc.
Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.